Baxter International Inc (BAX)
36.04
-0.07
(-0.19%)
USD |
NYSE |
Nov 07, 16:00
36.55
+0.51
(+1.42%)
After-Hours: 18:28
Baxter International Revenue (Annual): 14.81B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 14.81B |
December 31, 2022 | 14.51B |
December 31, 2021 | 12.15B |
December 31, 2020 | 11.67B |
December 31, 2019 | 11.36B |
December 31, 2018 | 11.10B |
December 31, 2017 | 10.58B |
December 31, 2016 | 10.16B |
December 31, 2015 | 9.968B |
December 31, 2014 | 10.72B |
December 31, 2013 | 9.413B |
December 31, 2012 | 13.94B |
December 31, 2011 | 13.89B |
December 31, 2010 | 12.84B |
December 31, 2009 | 12.56B |
December 31, 2008 | 12.35B |
December 31, 2007 | 11.26B |
December 31, 2006 | 10.38B |
December 31, 2005 | 9.849B |
December 31, 2004 | 9.509B |
Date | Value |
---|---|
December 31, 2003 | 8.904B |
December 31, 2002 | 8.099B |
December 31, 2001 | 7.356B |
December 31, 2000 | 6.697B |
December 31, 1999 | 6.38B |
December 31, 1998 | 5.706B |
December 31, 1997 | 5.259B |
December 31, 1996 | 5.438B |
December 31, 1995 | 5.048B |
December 31, 1994 | 9.324B |
December 31, 1993 | 8.879B |
December 31, 1992 | 8.471B |
December 31, 1991 | 8.921B |
December 31, 1990 | 8.10B |
December 31, 1989 | 7.399B |
December 31, 1988 | 6.861B |
December 31, 1987 | 6.223B |
December 31, 1986 | 5.543B |
December 31, 1985 | 2.355B |
December 31, 1984 | 1.800B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
11.36B
Minimum
2019
14.81B
Maximum
2023
12.90B
Average
12.15B
Median
2021
Revenue (Annual) Benchmarks
Boston Scientific Corp | 14.24B |
Haemonetics Corp | 1.309B |
Accuray Inc | 446.55M |
Masimo Corp | 2.048B |
Insulet Corp | 1.697B |